Previous close | 253.08 |
Open | 253.08 |
Bid | 261.10 |
Ask | 268.30 |
Strike | 560.00 |
Expiry date | 2025-12-19 |
Day's range | 253.08 - 253.08 |
Contract range | N/A |
Volume | |
Open interest | 36 |
Novo Nordisk CEO Lars Jørgensen tells Yahoo Finance the company is confident about a robust GLP-1 sales year despite missing Wall Street estimates.
The Danish pharmaceutical firm, Europe’s most valuable company, said sales of the weight-loss drug jumped 106% in the first quarter.
Eli Lilly and Company (NYSE:LLY) Q1 2024 Earnings Call Transcript April 30, 2024 Eli Lilly and Company beats earnings expectations. Reported EPS is $2.58, expectations were $2.47. Operator: Ladies and gentlemen, thank you for standing by, and welcome to the Lilly Q1 2024 Earnings Call. At this time all participants are in a listen-only mode. […]